Exactus Inc. (EXDI)
Stock Price Chart
Key Info
| Market Cap | 2.60M |
| Revenue (ttm) | 1.56M |
| Net Income (ttm) | -11.68M |
| Shares Out | 51.91M |
| EPS (ttm) | -0.27 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 16, 2020 |
| Last Price | $0.0500 |
| Previous Close | $0.0500 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.0500 |
| Day's Range | 0.0500 - 0.0500 |
| Day's Volume | 0 |
| 52-Week Range | 0.0403 - 0.8518 |
More Stats
| Market Cap | 2.60M |
| Enterprise Value | 3.60M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 51.91M |
| Float | 39.00M |
| EPS (basic) | -0.30 |
| EPS (diluted) | -0.27 |
| FCF / Share | -0.06 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | n/a |
| Short Ratio | n/a |
| Short % of Float | n/a |
| Beta | 5.33 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 1.67 |
| PB Ratio | 1.56 |
| Revenue | 1.56M |
| Operating Income | -11.47M |
| Net Income | -11.68M |
| Free Cash Flow | -2.82M |
| Net Cash | -1.00M |
| Net Cash / Share | -0.02 |
| Gross Margin | -93.13% |
| Operating Margin | -736.56% |
| Profit Margin | -749.80% |
| FCF Margin | -180.95% |
| ROA | -110.78% |
| ROE | -486.69% |
| ROIC | -270.60% |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.35 | - | - | - | - | - | - |
| Revenue Growth | - | - | - | - | - | 33.33% | - |
| Gross Profit | -1.70 | - | - | - | - | - | - |
| Operating Income | -10.88 | -2.44 | -3.12 | -1.60 | -0.39 | -0.42 | -0.11 |
| Net Income | -9.69 | -4.34 | -3.86 | -1.60 | -0.36 | -0.30 | -0.02 |
| Shares Outstanding | 33.90 | 4.76 | 4.24 | 0.30 | 0.01 | 0.01 | 0.01 |
| Earnings Per Share | -0.30 | -0.91 | -0.91 | -5.12 | -44.80 | -37.87 | - |
| Operating Cash Flow | -5.75 | -0.47 | -1.23 | -0.89 | -0.64 | -0.40 | - |
| Capital Expenditures | -0.54 | - | - | - | - | -0.01 | - |
| Free Cash Flow | -6.29 | -0.47 | -1.23 | -0.89 | -0.64 | -0.41 | - |
| Cash & Equivalents | 0.10 | 0.00 | 0.16 | 1.06 | 0.07 | 0.04 | 0.25 |
| Total Debt | 0.63 | 0.64 | 0.11 | - | 0.10 | - | - |
| Net Cash / Debt | -0.53 | -0.64 | 0.06 | 1.06 | -0.03 | 0.04 | 0.25 |
| Assets | 8.02 | 0.01 | 0.17 | 2.13 | 0.08 | 0.08 | 0.28 |
| Liabilities | 4.13 | 3.44 | 2.39 | 0.62 | 0.18 | 0.04 | 0.09 |
| Book Value | 4.43 | -3.42 | -2.22 | 1.50 | -0.09 | 0.05 | 0.19 |
Company Profile
Company Details
| Full Name | Exactus Inc. |
| Country | United States |
| CEO | Emiliano Aloi |
Stock Information
| Ticker Symbol | EXDI |
| Stock Exchange | US OTC |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | OTCMKTS: EXDI |
Description
Exactus produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.